Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Mom's voice may boost preemie feeding success

NCT ID NCT07068581

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times

Summary

This study tests whether playing a recording of a mother's voice during feeding helps preterm infants in the NICU. Researchers will measure oxygen levels, heart rate, breathing, and feeding skills in 50 infants. Half will hear their mother's voice; the other half will not. The goal is to see if this simple intervention can improve feeding and stability.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
maternal voice recording
What this could lead to
If it works, this could offer a simple, low-cost way to improve feeding and stability in preterm infants.
What could go wrong
This is a small, early-stage trial with only 50 infants, so results may not apply broadly. The effect may be small or hard to measure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

56 people

The number who actually took part.

Started

Aug 2025

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

1 day to 28 days

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Preterm infants born at gestational age ≥28 weeks and ≤34 weeks * Infants who are ≥30 postmenstrual weeks old at the time of enrollment * Infants weighing ≥1000 grams at the time of enrollment * Mothers aged 18 years or older * Preterm infants who have passed the hearing screening test * Infants whose mothers can provide an average of at least 30 ml of expressed breast milk daily during the study period. * Mothers who are Turkish speakers. * Infants for whom the decision to transition from enteral feeding to full oral feeding has been made for the first time jointly by the physician and nurse Exclusion Criteria: * Preterm infants with congenital anomalies. * Infants with a family history of congenital hearing loss. * Infants diagnosed with intraventricular hemorrhage (grade 3-4) or -periventricular leukomalacia. * Infants who have had necrotizing enterocolitis requiring treatment. * Infants whose mothers have a history of substance abuse or alcoholism

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Oral feeding performance are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Acibadem University

    Istanbul, 34260, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.